The Recall Desk

Manufacturer

A&H Focal Inc.

21 recalls in our database name A&H Focal Inc. as the manufacturing or recalling firm.

What the numbers show

Total
21
Critical
2
Severe
18
Most recent
2018-02-07

Of the 21 recalls from A&H Focal Inc. we have scored against our rubric, 2 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 18 (86%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–21 of 21

  • CriticalFDA (Drugs)·D-0563-2018·2018-02-07

    FDA Recalls Unapproved Zhonghua Niubian Tablets Containing Sildenafil

    A&H Focal Inc. is recalling Zhonghua Niubian tablets found to contain sildenafil, an unapproved drug for erectile dysfunction.

    Product
    Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • CriticalFDA (Drugs)·D-0558-2018·2018-02-07

    FDA Recalls Unapproved Sildenafil Tablets Sold in Asian Food Markets

    A&H Focal Inc. is recalling LANG YI HAO CHAONONGSUOPIAN tablets because they contain sildenafil without FDA approval. The products were sold in New York and New Jersey.

    Product
    LANG YI HAO CHAONONGSUOPIAN tablets, 500 mg, 8-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0559-2018·2018-02-07

    FDA Recalls Unapproved Gold Vigra Capsules Containing Sildenafil

    A&H Focal Inc. is recalling Gold Vigra capsules because they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    GOLD VIGRA capsules, 50mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0568-2018·2018-02-07

    FDA Recalls Unapproved Power V8 Viagra Tablets Containing Sildenafil

    A&H Focal Inc. is recalling Power V8 Viagra tablets because they contain sildenafil, an unapproved drug with unestablished safety and efficacy.

    Product
    Power V8 Viagra tablets, 200mg, 10-Grain bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0566-2018·2018-02-07

    Unapproved herbal capsules containing sildenafil recalled by FDA

    A&H Focal Inc. is recalling HU HU SHENG WEI capsules because FDA analysis found they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0571-2018·2018-02-07

    FDA Recalls MACA Gold Tablets Containing Unapproved Sildenafil

    A&H Focal Inc. is recalling MACA gold tablets sold in New York and New Jersey because they contain sildenafil, an unapproved drug.

    Product
    MACA gold tablets, 6800 mg, 10-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0556-2018·2018-02-07

    Germany Niubian tablets recalled for containing unapproved sildenafil

    A&H Focal Inc. is recalling Germany Niubian tablets because FDA analysis found they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0552-2018·2018-02-07

    FDA Recalls Unapproved Black Ant Capsules Containing Sildenafil

    A&H Focal Inc. is recalling Black Ant capsules found to contain sildenafil, an unapproved drug with unestablished safety and efficacy.

    Product
    Black Ant capsules, 4600mg, 4-count blister pack, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0572-2018·2018-02-07

    FDA Recalls Unapproved Tiger King Tablets Containing Sildenafil

    A&H Focal Inc. is recalling Tiger King tablets because they contain sildenafil, an unapproved drug for erectile dysfunction, and lack FDA approval.

    Product
    Tiger King tablets, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0567-2018·2018-02-07

    Unapproved Yanshijiaonang Capsules Containing Sildenafil Recalled by FDA

    A&H Focal Inc. is recalling Yanshijiaonang capsules because FDA analysis found they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    YANSHIJIAONANG capsules, 2000mg, 8-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0569-2018·2018-02-07

    FDA Recalls Unapproved Sildenafil Tablets Sold in Asian Food Markets

    A&H Focal Inc. is recalling DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets because they contain sildenafil, an unapproved drug for erectile dysfunction.

    Product
    DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0564-2018·2018-02-07

    STREE OVERLORD capsules recalled for containing unapproved sildenafil

    A&H Focal Inc. is recalling STREE OVERLORD capsules because FDA analysis found they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    STREE OVERLORD capsules, 3800 mg, 4-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0554-2018·2018-02-07

    FDA Recalls Unapproved Miraculous Evil Root Capsules Containing Sildenafil

    A&H Focal Inc. is recalling Miraculous Evil Root capsules because FDA analysis found they contain sildenafil, an unapproved drug with unestablished safety and efficacy.

    Product
    Miraculous Evil Root capsules, 1200 mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0560-2018·2018-02-07

    FDA Recalls Unapproved Clalis Capsules Containing Sildenafil

    A&H Focal Inc. is recalling Clalis capsules because they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    Clalis capsules, 50mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0562-2018·2018-02-07

    Unapproved Sildenafil Tablets Recalled by FDA for Lack of Safety Data

    The FDA is recalling ZHANSHENG WEIGE CHAOYUE XILISHI tablets because they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0565-2018·2018-02-07

    FDA Recalls Unapproved MAX MAN Capsules Containing Sildenafil

    A&H Focal Inc. is recalling MAX MAN capsules sold in New York and New Jersey because they contain sildenafil, an unapproved drug with unestablished safety and efficacy.

    Product
    MAX MAN capsules, 3000 mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0561-2018·2018-02-07

    Unapproved Ye Lang Shen capsules containing sildenafil recalled by FDA

    A&H Focal Inc. is recalling Ye Lang Shen capsules because FDA analysis found they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    Ye Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0555-2018·2018-02-07

    Germany Black Gold tablets recalled for containing unapproved sildenafil

    A&H Focal Inc. is recalling Germany Black Gold tablets because FDA analysis found they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    GERMANY BLACK GOLD tablets, 2800 mg, 8-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0570-2018·2018-02-07

    Unapproved Sildenafil Supplements Recalled by FDA for Lack of Safety Data

    A&H Focal Inc. is recalling LIEN CHAN FOR SEVEN DAYS capsules because they contain sildenafil, an unapproved drug with unestablished safety and efficacy.

    Product
    LIEN CHAN FOR SEVEN DAYS capsules, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0557-2018·2018-02-07

    FDA Recalls Unapproved Hard Ten Days Capsules Containing Sildenafil

    A&H Focal Inc. is recalling Hard Ten Days capsules because they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.

    Product
    HARD TEN DAYS capsules, 4500mg, 6-count bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states
  • LowFDA (Drugs)·D-0553-2018·2018-02-07

    Unapproved Indian God Lotion Spray Bottle Recalled by FDA

    A&H Focal Inc. is recalling Indian God Lotion Spray Bottles because the product is an unapproved drug containing diethyl phthalate.

    Product
    Indian God Lotion Spray Bottle, labeling is in foreign language
    Category
    Drug
    Distribution
    2 states